The basic pharmaceutical products and pharmaceutical preparations output in the Netherlands has shown a positive trend over the past decade. From a value of €5.03 billion in 2013, the market has grown to €10.33 billion in 2023. This represents a year-on-year increase of 8.74% from 2022 to 2023. The Compound Annual Growth Rate (CAGR) over the past five years has also been robust at 12.22%, indicative of a strong upward momentum in the industry.
The future forecast from 2024 to 2028 predicts a continued growth trend, with the market expected to reach €14.37 billion by 2028. The forecasted five-year CAGR is 5.2%, with an overall growth rate of 28.87% over this period.
Trends to watch for:
- Technological advancements in pharmaceutical manufacturing.
- Increasing investments in R&D and innovation.
- Potential regulatory changes impacting the industry.
- Growth in global demand for pharmaceutical products.
